Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Net Income (2016 - 2025)

Historic Net Income for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$19.8 million.

  • AC Immune's Net Income fell 41210.51% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year decrease of 8960.07%. This contributed to the annual value of -$58.1 million for FY2024, which is 491.25% up from last year.
  • Latest data reveals that AC Immune reported Net Income of -$19.8 million as of Q3 2025, which was down 41210.51% from -$25.6 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Net Income registered a high of $6.4 million during Q3 2024, and its lowest value of -$25.6 million during Q2 2025.
  • Moreover, its 5-year median value for Net Income was -$19.5 million (2022), whereas its average is -$17.8 million.
  • Its Net Income has fluctuated over the past 5 years, first surged by 13706.28% in 2024, then tumbled by 41210.51% in 2025.
  • Quarter analysis of 5 years shows AC Immune's Net Income stood at -$23.1 million in 2021, then increased by 15.66% to -$19.5 million in 2022, then skyrocketed by 72.53% to -$5.3 million in 2023, then crashed by 237.25% to -$18.0 million in 2024, then fell by 9.95% to -$19.8 million in 2025.
  • Its last three reported values are -$19.8 million in Q3 2025, -$25.6 million for Q2 2025, and -$21.2 million during Q1 2025.